Literature Citations
1. Anti-tubercular Activity of Novel 4-Anilinoquinolines and 4-Anilinoquinazolines. Asquith, C.R.M., N. Fleck, C.D. Torrice, D.J. Crona, C. Grundner, and W.J. Zuercher. Bioorganic and Medicinal Chemistry Letters, 2019. 29(18): p. 2695-2699. PMID[31378571]. PMCID[PMC6736633].
[PubMed]. TB_09_2019.
2. Synthesis, Biological Evaluation and Computational Study of Novel Isoniazid Containing 4H-Pyrimido[2,1-b]benzothiazoles Derivatives. Bhoi, M.N., M.A. Borad, D.J. Jethava, P.T. Acharya, E.A. Pithawala, C.N. Patel, H.A. Pandya, and H.D. Patel. European Journal of Medicinal Chemistry, 2019. 177: p. 12-31. PMID[31129451].
[PubMed]. TB_09_2019.
3. Antimicrobial Lavandulylated Flavonoids from a Sponge-Derived Streptomyces sp. G248 in East Vietnam Sea. Cao, D.D., T.T.V. Trinh, H.D.T. Mai, V.N. Vu, H.M. Le, Q.V. Thi, M.A. Nguyen, T.T. Duong, D.T. Tran, V.M. Chau, R. Ma, G. Shetye, S. Cho, B.T. Murphy, and V.C. Pham. Marine Drugs, 2019. 17(9): p. p 11. PMID[31510079].
[PubMed]. TB_09_2019.
4. New Isoniazid Derivatives with Improved Pharmaco-toxicological Profile: Obtaining, Characterization and Biological Evaluation. Dragostin, I., O.M. Dragostin, S.K. Samal, S. Dash, R. Tatia, M. Dragan, L. Confederat, C.M. Ghiciuc, D. Diculencu, C.E. Lupusoru, and C.L. Zamfir. European Journal of Pharmaceutical Sciences, 2019. 137: e104974. PMID[31252051].
[PubMed]. TB_09_2019.
5. In-Vitro Evaluation of the Antibacterial Activity of the Essential Oils of Micromeria barbata, Eucalyptus globulus and Juniperus excelsa Against Strains of Mycobacterium tuberculosis (Including MDR), Mycobacterium kansasii and Mycobacterium gordonae. El Omari, K., M. Hamze, S. Alwan, M. Osman, C. Jama, and N.E. Chihib. Journal of Infection and Public Health, 2019. 12(5): p. 615-618. PMID[30738755].
[PubMed]. TB_09_2019.
6. Synthesis, Characterization, and in Vitro Evaluation of Gamma Radiation-induced Pegylated Isoniazid. Gonzalez-Torres, M., S. Guzman-Beltran, M.A. Mata-Gomez, J. Gonzalez-Valdez, G. Leyva-Gomez, Y. Melgarejo-Ramirez, W. Brostow, C. Velasquillo, J. Zuniga-Ramos, and R. Rodriguez-Talavera. Electronic Journal of Biotechnology, 2019. 41: p. 81-87. ISI[000484693400011].
[WOS]. TB_09_2019.
7. Identification of 4-Amino-thieno[2,3-d]pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis. Harrison, G.A., A.E. Mayer Bridwell, M. Singh, K. Jayaraman, L.A. Weiss, R.L. Kinsella, J.S. Aneke, K. Flentie, M.E. Schene, M. Gaggioli, S.D. Solomon, S.A. Wildman, M.J. Meyers, and C.L. Stallings. mSphere, 2019. 4(5): p. 606-619. PMID[31511370]. PMCID[PMC6739496].
[PubMed]. TB_09_2019.
8. Synthesis and Photophysical, Thermal and Antimycobacterial Properties of Novel 6-Amino-2-alkyl (aryl/heteroaryl)-4-(trifluoromethyl) quinolines. Kappenberg, Y.G., A. Ketzer, F.S. Stefanello, P.R.S. Salbego, T.V. Acunha, B.L. Abbadi, C.V. Bizarro, L.A. Basso, P. Machado, M.A.P. Martins, N. Zanatta, B.A. Iglesias, and H.G. Bonacorso. New Journal of Chemistry, 2019. 43(31): p. 12375-12384. ISI[000480521500020].
[WOS]. TB_09_2019.
9. Development of 3,5-Dinitrophenyl-containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-beta-D-ribofuranose 2'-Oxidase. Karabanovich, G., J. Dusek, K. Savkova, O. Pavlis, I. Pavkova, J. Korabecny, T. Kucera, H. Kocova Vlckova, S. Huszar, Z. Konyarikova, K. Konecna, O. Jand'ourek, J. Stolarikova, J. Kordulakova, K. Vavrova, P. Pavek, V. Klimesova, A. Hrabalek, K. Mikusova, and J. Roh. Journal of Medicinal Chemistry, 2019. 62(17): p. 8115-8139. PMID[31393122].
[PubMed]. TB_09_2019.
10. Investigation of 5'-Norcarbocyclic nucleoside Analogues as Antiprotozoal and Antibacterial Agents. Khandazhinskaya, A.L., E.S. Matyugina, P.N. Solyev, M. Wilkinson, K.W. Buckheit, R.W. Buckheit, Jr., L.N. Chernousova, T.G. Smirnova, S.N. Andreevskaya, K.J. Alzahrani, M.J. Natto, S.N. Kochetkov, H.P. de Koning, and K.L. Seley-Radtke. Molecules, 2019. 24(19): p. 16. PMID[31546633].
[PubMed]. TB_09_2019.
11. 1H-Benzo[d]imidazole Derivatives Affect MmpL3 in Mycobacterium tuberculosis. Korycka-Machala, M., A. Viljoen, J. Pawelczyk, P. Borowka, B. Dziadek, K. Gobis, A. Brzostek, M. Kawka, M. Blaise, D. Strapagiel, L. Kremer, and J. Dziadek. Antimicrobial Agents and Chemotherapy, 2019. 63(10): e00441-00419. PMID[31332069]. PMCID[PMC6761528].
[PubMed]. TB_09_2019.
12. In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl. Pinzi, L., C. Lherbet, M. Baltas, F. Pellati, and G. Rastelli. Molecules. 24(14): p. e2567. PMID[31311157]. PMCID[PMC6680637].
[PubMed]. TB_09_2019.
13. Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors that Impair Growth of Mycobacterium abscessus. Madani, A., J.N. Ridenour, B.P. Martin, R.R. Paudel, A. Abdul Basir, V. Le Moigne, J.L. Herrmann, S. Audebert, L. Camoin, L. Kremer, C.D. Spilling, S. Canaan, and J.F. Cavalier. ACS Infectious Diseases, 2019. 5(9): p. 1597-1608. PMID[31299146].
[PubMed]. TB_09_2019.
14. 5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as Dual Inhibitors of Mycobacterium tuberculosis and Influenza Virus: Synthesis and Evaluation. Marvadi, S.K., V.S. Krishna, E.O. Sinegubova, A.S. Volobueva, Y.L. Esaulkova, A.A. Muryleva, D.G. Tentler, D. Sriram, V.V. Zarubaev, and S. Kantevari. Bioorganic and Medicinal Chemistry Letters, 2019. 29(18): p. 2664-2669. PMID[31375291].
[PubMed]. TB_09_2019.
15. Comparative Structure-activity Analysis of the Antimicrobial Activity, Cytotoxicity, and Mechanism of Action of the Fungal Cyclohexadepsipeptides Enniatins and Beauvericin. Olleik, H., C. Nicoletti, M. Lafond, E. Courvoisier-Dezord, P. Xue, A. Hijazi, E. Baydoun, J. Perrier, and M. Maresca. Toxins, 2019. 11(9): p. 514. PMID[31484420].
[PubMed]. TB_09_2019.
16. Synthesis and Evaluation of a Novel Quinoline-triazole Analogs for Antitubercular Properties via Molecular Hybridization Approach. Ramprasad, J., V. Kumar Sthalam, R. Linga Murthy Thampunuri, S. Bhukya, R. Ummanni, S. Balasubramanian, and S. Pabbaraja. Bioorganic and Medicinal Chemistry Letters, 2019. 29(20): p. 126671. PMID[31526604].
[PubMed]. TB_09_2019.
17. Design of Hybrid Molecules as Antimycobacterial Compounds: Synthesis of Isoniazid-naphthoquinone Derivatives and their Activity Against Susceptible and Resistant Strains of Mycobacterium tuberculosis. Reis, W.J., I.A.O. Bozzi, M.F. Ribeiro, P.C.B. Halicki, L.A. Ferreira, P.E. Almeida da Silva, D.F. Ramos, C.A. de Simone, and E.N. da Silva Junior. Bioorganic and Medicinal Chemistry, 2019. 27(18): p. 4143-4150. PMID[31378595].
[PubMed]. TB_09_2019.
18. Antitubercular Metabolites from the Marine-derived Fungus Strain Aspergillus fumigatus MF029. Song, Z.J., Y. Liu, J.Y. Gao, J.S. Hu, H.T. He, S.W. Dai, L.Q. Wang, H.Q. Dai, L.X. Zhang, and F.H. Song. Natural Product Research, 2019. p. 1-8. ISI[000485535500001].
[WOS]. TB_09_2019.
19. Discovery and Evaluation of Novel Nitrodihydroimidazooxazoles as Promising Anti-tuberculosis Agents. Tao, X., C. Gao, Z.G. Huang, W. Luo, K.L. Liu, C.T. Peng, C.Z. Ding, J. Li, S.H. Chen, and L.T. Yu. Bioorganic and Medicinal Chemistry Letters, 2019. 29(17): p. 2511-2515. PMID[31353295].
[PubMed]. TB_09_2019.
20. Design, Synthesis and Antimycobacterial Activity of Benzoxazinone Derivatives and Open-ring Analogues: Preliminary Data and Computational Analysis. Zampieri, D., M.G. Mamolo, J. Filingeri, S. Fortuna, A. De Logu, A. Sanna, and D. Zanon. Bioorganic and Medicinal Chemistry Letters, 2019. 29(17): p. 2468-2474. PMID[31350124].
[PubMed]. TB_09_2019.
21. Comparison of In Vitro Synergistic Effect between Clarithromycin or Azithromycin in Combination with Amikacin against Mycobacterium intracellulare. Zhang, Z., J. Lu, Y. Du, F. Xie, Y. Wang, B. Sun, and Y. Pang. Journal of Global Antimicrobial Resistance, 2019. 18: p. 183-186. PMID[30953831].
[PubMed]. TB_09_2019.
22. Sesquiterpenoids from Pilea cavaleriei. Zhou, Y., L.Y. Li, X. Yin, Q.Y. Zhang, H. Liang, and P.F. Tu. Natural Product Research, 2019. p. 1-7. ISI[000485131800001].
[WOS]. TB_09_2019.
Patent Citations
23. Deuterated Imidazopyridines.Liu, R., M.J. Miller, and G.C. Moraski. Patent. 2019. 2019-IB51934 2019175737: 92pp.
[Patent]. TB_09_2019.
24. Use of Fatty acid Oxidation Inhibitors as Antimicrobials. Philips, J.A., K. Moore, P. Chandra, and M. Ouimet. Patent. 2019. 2019-US22457 2019178472: 46pp.
[Patent]. TB_09_2019.